News from Bayer
May 13, 2022
New pharmaceutical production plant
Chancellor Olaf Scholz attends topping-out ceremony in Leverkusen
May 10, 2022
First quarter at Bayer:
Very good start to the year – strong sales and earnings growth
May 03, 2022
Not intended for U.S. and UK Media
U.S. FDA accepts supplemental new drug application (sNDA) and grants priority review for darolutamide in combination with docetaxel for metastatic hormone-sensitive prostate cancer (mHSPC)